USPTO serial 79359159
BOTYL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 10, 2024
- Examiner
- MCNAMARA, SHANA MARIE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BOTYL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer application software for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; Downloadable communication software for providing access to the Internet; computer hardware for use in computer-assisted software engineering; Downloadable computer modelling language software; Downloadable computer software for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; Downloadable computer software programs for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; Downloadable computer software adapted for use in the operation of computers for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; Downloadable computer software applications for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; Downloadable computer software from the internet for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; Downloadable computer software for authorising access to data bases; Downloadable computer software for business purposes for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; Downloadable computer software programs for use in database management; Downloadable computer software programs for use in spreadsheet management; Downloadable data communications software for use in the pharmaceutical, medical and scientific industry; Downloadable data processing software; downloadable computer programs and recorded software distributed online for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; downloadable software applications for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; Downloadable computer software for use in engineering design; downloadable interactive computer software for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; downloadable simulation software for use in digital computers for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; Downloadable computer software for use in table representation; Downloadable computer programs for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry, all for medical purposes; Downloadable computer programs for data processing; Downloadable computer programs for processing information; Downloadable computer programs for providing a graphical presentation of data; Downloadable computer programs for use in the analysis of data processing efficiency; Downloadable computer programs for use in the analysis of data processing performance; Downloadable computer programs for use in the analysis of data processing procedures; Downloadable computer programs for use in computer aided engineering; Downloadable computer programs for use in database management; Downloadable computer programs for use in developing computer programs; Downloadable computer programs for use in molecular biology for designing, analysing, researching and testing artificial intelligence solutions; Downloadable computer programs in the field of molecular modelling for designing, analysing, researching and testing artificial intelligence solutions; Downloadable computer programs relating to computer aided design for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; Downloadable computer programs for use in the creation of graphic images; Recorded computer programs stored in digital form for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; Downloadable computer programs for use in molecular biology for designing, analysing, researching and testing artificial intelligence solutions; computer programs, downloadable, for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; Electronic computer databases for designing, analysing, researching and testing artificial intelligence solutions in the field of pharmaceutical, medical and scientific industry recorded on computer media; Downloadable computer database software programs for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; downloadable database management software for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; Data feeders linked with artificial intelligence, namely, downloadable software using artificial intelligence for data feeding; recorded computer programs for use in conducting scientific research | ACTIVE | — |
| 042 | Consultancy in the field of artificial intelligence technology; research in the field of artificial intelligence technology; advisory services relating to scientific research; advisory services relating to technological research; scientific research; biochemistry research services; biological research; biotechnological research; chemical technological research; conducting of feasibility studies, namely, scientific research; engineering research, namely, genetic engineering research; medical research, namely, scientific research for medical purposes; pharmaceutical research services; preparation of reports relating to chemical research; preparation of reports relating to scientific research; preparation of reports relating to technical research; providing information, including online, about industrial analysis and research services; providing information, including online, about scientific and technological services and research and design relating thereto; provision of information relating to scientific research; research relating to data processing; research relating to science; research relating to technology; research, engineering and technical consultancy for industry; technological research; hosting of software as a service (SaaS) for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; software as a service (SaaS) for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; platform as a service (PaaS) for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; computer software development; design and development of computer software; development of computer platforms; development of computer programmes; development of computer software; development of computer software application solutions; development of on-line computer software systems; development of systems for the processing of data; development of systems for the storage of data; development of systems for the transmission of data; providing online information about design and development of computer hardware and software; advisory services relating to biochemistry; biochemistry services; online provision of non-downloadable web-based software applications for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; online provision of non-downloadable web-based software for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry; provision of online non-downloadable software, namely, application service provider services for designing, analysing, researching and testing artificial intelligence solutions for use in the pharmaceutical, medical and scientific industry | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PENDING IP PROPRIETARY LIMITED
- Other trademarks owned by PENDING IP PROPRIETARY LIMITED
- Other trademarks owned by PENDING IP PROPRIETARY LIMITED
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named BOTYL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 9, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 18, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 18, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 10, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 10, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 10, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 1, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 30, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 25, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 25, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 11, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 11, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 7, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 7, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 5, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 21, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 16, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 16, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 1, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 1, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 1, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 1, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 1, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 1, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 6, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 16, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 16, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 1, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 30, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 10, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 5, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 4, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 30, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |